70
Participants
Start Date
December 31, 2003
Study Completion Date
June 30, 2004
T0903131 Besylate
Once daily, oral
Placebo
Once daily, oral
Whittier Diabetes Institute, La Jolla
Charles R. Drew University, Los Angeles
National Research Institute, Los Angeles
Lovelace Research Institute, Santa Ana
University of Miami, Miami
GFI Research Center, Evansville
Joslin Diabetes Center, Boston
Radiant Research, Edina
Radiant Research, St Louis
St Louis Center for Clinical Research, St Louis
Kaleida Health Diabetes Center, Buffalo
Rochester Clinical Research, Rochester
Duke University Medical Center, Durham
Radiant Research, Portland
Radiant Research, Anderson
Baylor University Endocrine Center, Dallas
Dallas Diabetes and Endocrine Research Center, Dallas
Endocrine Associates of Dallas, Dallas
Diabetes and Grandular Disease Clinic and Reseach Center, San Antonio
Endocrine Research Specialists, Ogden
Salem VA Medical Center, Salem
Lead Sponsor
InteKrin Therapeutics, Inc.
INDUSTRY